Information Provided By:
Fly News Breaks for April 12, 2019
RCM
Apr 12, 2019 | 07:39 EDT
Cantor Fitzgerald analyst Steven Halper raised his price target for R1 RCM to $13 from $11 and reiterates an Overweight rating on the shares after hosting investor meetings with management. The company continues to estimate its total addressable market at about $100B, with about 70% spent internally by hospitals and physician offices, Halper tells investors in a research note. He believes R1 RCM's competitive position is strong and increased his out-year margin assumptions.
News For RCM From the Last 2 Days
There are no results for your query RCM